Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Guidance on cannabis-based products

NHS England has issued guidance on the use of cannabis-based products for medicinal use.

Following high-profile news stories over the summer, the Home Office reviewed the legal status of cannabis-based products for medicinal use. In light of evidence of therapeutic benefit in certain medical conditions these products will be rescheduled.

The guidance document notes that cannabis-based products for medicinal use should only be prescribed:

  • for indications where there is clear published evidence of benefit or UK
    Guidelines
  • where there is a clinical need which cannot be met by a licensed medicine
  • where established treatment options have been exhausted
  • under the prescription or direction of a specialist doctor (listed on the Specialist Register of the General Medical Council)

Action: Clinicians should be aware of this guidance. It essentially rules out prescribing in primary care and places restrictions on specialist prescribing.

Share 'Guidance on cannabis-based products' on Email Share 'Guidance on cannabis-based products' on Delicious Share 'Guidance on cannabis-based products' on Digg Share 'Guidance on cannabis-based products' on Facebook Share 'Guidance on cannabis-based products' on reddit Share 'Guidance on cannabis-based products' on StumbleUpon Share 'Guidance on cannabis-based products' on Twitter

atomic-wealth

No Comments to “Guidance on cannabis-based products”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer